These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15342691)

  • 1. Requirement of PPARalpha in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation.
    Lee SS; Chan WY; Lo CK; Wan DC; Tsang DS; Cheung WT
    J Lipid Res; 2004 Nov; 45(11):2025-37. PubMed ID: 15342691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha is required for feedback regulation of highly unsaturated fatty acid synthesis.
    Li Y; Nara TY; Nakamura MT
    J Lipid Res; 2005 Nov; 46(11):2432-40. PubMed ID: 16106047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep profile during fasting in PPAR-alpha knockout mice.
    Kondo Y; Chikahisa S; Shiuchi T; Shimizu N; Tanioka D; Uguisu H; Séi H
    Physiol Behav; 2020 Feb; 214():112760. PubMed ID: 31785270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.
    Patsouris D; Reddy JK; Müller M; Kersten S
    Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
    van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
    J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.
    Guo Y; Yu J; Deng J; Liu B; Xiao Y; Li K; Xiao F; Yuan F; Liu Y; Chen S; Guo F
    Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA G23Rik attenuates fasting-induced lipid accumulation in mouse liver.
    Kim D; Kim B; Brocker CN; Karri K; Waxman DJ; Gonzalez FJ
    Mol Cell Endocrinol; 2022 Nov; 557():111722. PubMed ID: 35917881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response.
    Lutkewitte AJ; McCommis KS; Schweitzer GG; Chambers KT; Graham MJ; Wang L; Patti GJ; Hall AM; Finck BN
    J Lipid Res; 2019 Mar; 60(3):528-538. PubMed ID: 30610082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Fasting-Induced PPARα Activity Does Not Depend on Essential Fatty Acids.
    Polizzi A; Fouché E; Ducheix S; Lasserre F; Marmugi AP; Mselli-Lakhal L; Loiseau N; Wahli W; Guillou H; Montagner A
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.
    Shao M; Shan B; Liu Y; Deng Y; Yan C; Wu Y; Mao T; Qiu Y; Zhou Y; Jiang S; Jia W; Li J; Li J; Rui L; Yang L; Liu Y
    Nat Commun; 2014 Mar; 5():3528. PubMed ID: 24670948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation.
    Gremlich S; Nolan C; Roduit R; Burcelin R; Peyot ML; Delghingaro-Augusto V; Desvergne B; Michalik L; Prentki M; Wahli W
    Endocrinology; 2005 Jan; 146(1):375-82. PubMed ID: 15459119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.